Finally, for the main compounds identified here as NMT inhibitors against leishmaniasis, malaria, and HAT, Table 1 highlights the most promising developments that can guide researchers in using CADD methods to discover new drugs against these diseases. This evidence concerns the gene NMT1 and leishmaniasis.